Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 2
1993 1
1994 3
1995 2
1996 2
1997 7
1998 7
1999 10
2000 6
2001 11
2002 22
2003 21
2004 14
2005 1
2006 5
2007 8
2008 10
2009 9
2010 3
2011 13
2012 13
2013 13
2014 9
2015 9
2016 10
2017 14
2018 22
2019 27
2020 19
2021 22
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

309 results
Results by year
Filters applied: . Clear all
Page 1
Comparative review of the carbapenems.
Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA. Zhanel GG, et al. Among authors: karlowsky ja. Drugs. 2007;67(7):1027-52. doi: 10.2165/00003495-200767070-00006. Drugs. 2007. PMID: 17488146 Review.
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG, Golden AR, Zelenitsky S, Wiebe K, Lawrence CK, Adam HJ, Idowu T, Domalaon R, Schweizer F, Zhanel MA, Lagacé-Wiens PRS, Walkty AJ, Noreddin A, Lynch Iii JP, Karlowsky JA. Zhanel GG, et al. Among authors: karlowsky ja. Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
Zhanel GG, Esquivel J, Zelenitsky S, Lawrence CK, Adam HJ, Golden A, Hink R, Berry L, Schweizer F, Zhanel MA, Bay D, Lagacé-Wiens PRS, Walkty AJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: karlowsky ja. Drugs. 2020 Feb;80(3):285-313. doi: 10.1007/s40265-020-01257-4. Drugs. 2020. PMID: 31970713 Review.
Microbiology and Preclinical Review of Omadacycline.
Karlowsky JA, Steenbergen J, Zhanel GG. Karlowsky JA, et al. Clin Infect Dis. 2019 Aug 1;69(Suppl 1):S6-S15. doi: 10.1093/cid/ciz395. Clin Infect Dis. 2019. PMID: 31367743 Free PMC article. Review.
Aminoglycoside adaptive resistance.
Karlowsky JA, Zelenitsky SA, Zhanel GG. Karlowsky JA, et al. Pharmacotherapy. 1997 May-Jun;17(3):549-55. Pharmacotherapy. 1997. PMID: 9165557 Review.
Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.
Zhanel GG, Lawson CD, Adam H, Schweizer F, Zelenitsky S, Lagacé-Wiens PR, Denisuik A, Rubinstein E, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: karlowsky ja. Drugs. 2013 Feb;73(2):159-77. doi: 10.1007/s40265-013-0013-7. Drugs. 2013. PMID: 23371303 Review.
Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19.
Zhanel GG, Zhanel MA, Boreskie KF, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: karlowsky ja. Can J Infect Dis Med Microbiol. 2021 Sep 15;2021:5942366. doi: 10.1155/2021/5942366. eCollection 2021. Can J Infect Dis Med Microbiol. 2021. PMID: 34557260 Free PMC article. Review.
Tigecycline: a novel glycylcycline antibiotic.
Zhanel GG, Karlowsky JA, Rubinstein E, Hoban DJ. Zhanel GG, et al. Among authors: karlowsky ja. Expert Rev Anti Infect Ther. 2006 Feb;4(1):9-25. doi: 10.1586/14787210.4.1.9. Expert Rev Anti Infect Ther. 2006. PMID: 16441206 Review.
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
Zhanel GG, Cheung D, Adam H, Zelenitsky S, Golden A, Schweizer F, Gorityala B, Lagacé-Wiens PR, Walkty A, Gin AS, Hoban DJ, Karlowsky JA. Zhanel GG, et al. Among authors: karlowsky ja. Drugs. 2016 Apr;76(5):567-88. doi: 10.1007/s40265-016-0545-8. Drugs. 2016. PMID: 26863149 Review.
309 results